Al-Razi Medical Co. (9572.SR)
SAR 55.9
(2.57%)
SAR 55.9
(2.57%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.45 SAR | -66.17% |
| 2022 | 1.33 SAR | -6.34% |
| 2021 | 1.42 SAR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.00 SAR | 0.0% |
| 2024 Q1 | 0.00 SAR | -87.4% |
| 2023 Q3 | 0.03 SAR | -86.9% |
| 2023 Q4 | 0.03 SAR | 0.0% |
| 2023 FY | - SAR | -66.17% |
| 2023 Q2 | 0.20 SAR | 0.0% |
| 2023 Q1 | 0.20 SAR | -57.45% |
| 2022 FY | - SAR | -6.34% |
| 2022 Q4 | 0.47 SAR | 0.0% |
| 2021 FY | - SAR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 3.29 SAR | 86.322% |
| Al-Dawaa Medical Services Company | 3.87 SAR | 88.372% |
| Nahdi Medical Company | 6.87 SAR | 93.45% |
| Almujtama Alraida Medical Co. | 1.20 SAR | 62.5% |